Search All News
Meet our new faculty!
Dr. Olajide Williams, Chief of Staff of Neurology at Columbia University, discusses Hip Hop Public Health's campaign to reach and educate communities of color about vaccines.
The universal marker of aging is not always a one-way process.
- June 13, 2021
A public battle rages over access to experimental, trial-phase drugs
- June 9, 2021
After her diagnosis of glioblastoma in 2016, she founded an organization that advocated for patients and research.
- June 8, 2021
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
- June 7, 2021
It’s clear the virus can get very close to the brain. What’s less certain is whether virus is able to penetrate deeper and invade it.
Source:PreventionMay 21, 2021
For someone to be diagnosed with dementia, they have to have significant decline in more than one cognitive area,” says Neuropsychologist Elise Caccappolo, Ph.D., of CUIMC
Source:ForbesMay 21, 2021
It is well established that people who had fewer opportunities to receive education when they were children are at higher risk for Alzheimer’s disease later in life, noted Dr. Jennifer Manly
- May 10, 2021
Webinar recordings of the event, “Transitions in Children with Autism,” from the 3rd Annual Autism Awareness Virtual Community Outreach Fair.
Source:The Washington PostApril 26, 2021
Successful messaging isn’t only about finding the right words. Olajide Williams, a Columbia University neurologist, uses music and art